Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: Functional analysis in T cell hybridoma

Journal of Immunology

Volumn 161, Issue 7, 1998, Pages 3469-3473

  Matsui, Ken ^a   Fine, Alan ^a   Zhu, Bangmin ^a   Marshak Rothstein, Ann ^a   Ju, Shyr Te ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ARTICLE; GENE ACTIVATION; GENE EXPRESSION REGULATION; HYBRIDOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE;

EID: 0032194170     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by point mutation in the Fas ligand. Cell 76:969.
2. 2+ independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
3. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185.
4. Dhein, J., H. Walczak, C. Baumier, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1(Fas/CD95). Nature 373:438.
5. Brunner, T., R. J. Mogil, D. Laface, N. J. Yoo, A. Mahboudi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
6. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein.1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
7. Rothstein, T. L., J. K. M. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163.
8. Matsui, M., S. Omura, H. Cui, S. L. Schauer, G. E. Sonenshein, and S.T. Ju. 1997. Proteasome regulation of Fas ligand cytotoxicity. Eur. J. Immunol. 27:2269.
9. Cui, H., K. Matsui, S. Omura, S. L. Schauer, R. A. Matulka, G. E. Sonenshein, and S. T. Ju. 1997. Proteasome regulation of activation-induced T cell death. Proc. Natl. Acad. Sci. USA 94:7515.
10. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
11. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726.
12. Ivanov, V. N., R. K. Lee, E. R. Podack, and T. R. Malek. 1997. Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-κB. Oncogene 14:2455.
13. Cui, H., M. El-Khatib. D. H. Sherr, R. Ettinger, M.-S Sy, A. Marshak-Rothstein, and S.-T. Ju. 1996. Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation. Cell. Immunol. 167:302.
14. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705.
15. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T. Suda, and S. Nagata. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 5:1567.